During the week beginning January 16th, the GIFT study convened for its official investigators’ meeting in Boschendal, South Africa. The study aims to test the Genital Inflammation Test (GIFT) in clinical trial setting among women from South Africa, Madagascar, and Zimbabwe. On the first few days, the Zimbabwe, South Africa and Madagascar sites of the study met to discuss the study’s progress to date and timelines. Each site had the opportunity to explain how they operate in an effort to strengthen synergy across board. The study’s work packages were presented to the strategic advisory board and gained professional advice on strategy going forward. After the main meeting, a training was held for the third work package which involves the implementation of the GIFT device at family planning clinic level targeted at women between the ages of 18-35 years. The main procedures of the study were thoroughly covered.
- mufaronashe